NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: DKMC, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Daya Medicals, Inc. to Introduce the MedPod - A Breakthrough in Telehealth on December 9 - Daya Medicals, Inc. will present its game-changing patient-centered medication dispensing and data coordinating “cloud” based hub, the MedPod, for the first time to a select group of industry specialists and health care professionals
Daya Medicals, Inc. to Introduce the MedPod - A Breakthrough in Telehealth on December 9

 

NewswireTODAY - /newswire/ - Hollywood, FL, United States, 2010/12/06 - Daya Medicals, Inc. will present its game-changing patient-centered medication dispensing and data coordinating “cloud” based hub, the MedPod, for the first time to a select group of industry specialists and health care professionals.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

On December 9 at 11am at the Four Seasons Hotel located at 1435 Brickell Avenue in Miami, Daya Medicals, Inc. will present its game-changing patient-centered medication dispensing and data coordinating “cloud” based hub (newest product), the MedPod, to a select group of industry specialists and health care professionals. This will be the first public viewing and demonstration of the product.

The MedPod unit designed by Daya Medicals, Inc. fits in the palm of a hand, is mobile, and is simple to use. All units are pre stocked with prescribed patient-customized drug dosages (prescribed medication) and patient reminder alerts, with light and sound, before being shipped to the patient’s door. The unit does require any wifi connection as it uses a cellular technology for communication. Hi-tech tracking allows the physician and any HIPAA approved need-to-know individual in the patient’s ecosystem (and/or caregiver) to connect with the patient on a real time basis. Patients maintain compliance with medications and dosing while remaining in control of their home health care.

The MedPod is designed to cut health care costs and risks while increasing patient responsibility, compliance, communication, benefits of home health care, control, and peace of mind. The MedPod’s inherent telehealth capabilities empower management of fraud and lowers costs. Due to its effective and efficient variety of applications and benefits, initial testing of Daya Medicals, Inc.’s MedPod has already received rave reviews and prescribers from well respected health care providers, government officials, economists, unions, insurance companies, human resources specialists, doctors, hospitals, among others.

Daya Medicals, Inc. plans to manufacture the medication cartridges at their new facility, the life sciences and technology park on campus at the University of Miami, located at 1951 NW 7th Avenue in Miami, initially creating close to 60 jobs in the (initial) introductory phase. Chief Executive and Medical Officer Dr. Kanti Daya says, “The MedPod is unique in that it addresses today’s concerns for cost and quality control with health care reform as well as the growing and future needs of general health care. With the expanding growth of the market, it’s harder to address both patient and health care provider needs. A unit like MedPod allows patients to help themselves and creates a win-win for all parties, building stronger and more synergistic relationships.” Daya adds that additional benefits include insurance incentives, lower drug confusion and abuse, and increased lines of communication between caregiver and patient, eliminating errors, fraud, and waste.

About Daya Medicals, Inc.

Daya Medicals, Inc. (dayamed.com) is a Pharmaceutical Company with the Prime Directive of Sanitas Pro Omnibus – Health for all. The company empowers and vigorously partners with patients to address diseases and mitigate debility by ameliorating the experiences of aging. These objectives are achieved by minimizing the invasiveness of treatments and enhancing compliance, by expanding access to and integration of data and information on a patient customized basis, by utilizing patient customized clinical information to drive care delivery and minimize errors, and by recognizing and reducing the role of cost to customized patient outcomes. DayaMed has developed next generation technology to achieve these objectives.

The company is additionally fortified with three proprietary products, CarvasinTM – Cardiovascular and Cerebrovascular pathology therapeutic regimen, (Heart Disease Protocol Medication), DST - a Syphilis Screening Test utilized by the US DoD, and The D-Mantoux Tuberculosis Test with two FDA approvals and a third eminently pending Phase One Trials. The portfolio of products includes cardiovascular products, Infectious Disease products, over two hundred generics, laboratory equipment and Diagnostic products.

RSVP is required by emailing RSVP[.]dayamed.com or by calling.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: DKMC, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Daya Medicals, Inc. to Introduce the MedPod - A Breakthrough in Telehealth on December 9

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
dayamed.com |
Contact: Dana Klein - DKMC.com 
954-923-4343 dklein[.]dkmc.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any DKMC, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From DKMC, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC
Ipsen Receives CHMP Negative Opinion for Palovarotene as A Treatment for Fibrodysplasia Ossificans Progressiva in E.U
Ipsen Presents Positive Results from the Pivotal Phase III NAPOLI 3 Trial Evaluating An Investigational Regimen of Onivyde®
SCHOTT Opens First Facility in U.S. to Increase Capabilities and Capacity for Development and Manufacturing of Diagnostics and Life Sciences Products
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
Ipsen Demonstrates Commitment to Innovation in Neuroscience At 12th World Congress for Neurorehabilitation (WCNR)
BASF Pharma Solutions Excipient Accepted into FDA Pilot Program for Novel Excipients
Digital Technologies Drive Growth Across the Biomanufacturing Value Chain Finds Frost & Sullivan
DSM Starts Construction of Large Scale Production Facility for its Novel Methane-reducing Feed Additive for Ruminants, Bovaer® in Dalry, Scotland
Collaboration Between Drug and Medical Food Manufacturers to Boost Market Growth Says Frost & Sullivan
Parexel Recognized by Frost & Sullivan with 2022 Global Customer Value Leadership Award
Ipsen’s Global Natural History Study of Fibrodysplasia Ossificans Progressiva Shows Debilitating Impact of the Disease Over An Individual’s Lifetime
BASF and Evonik Partner to Reduce the Environmental Footprint of the Feed and Animal Protein Industries
Rely+On Virkon from LANXESS Effective Against Monkeypox Virus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Sublime SEO

Visit  BizJobs.com





 
  ©2005-2023 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)